Zobrazeno 1 - 10
of 672
pro vyhledávání: '"Remes, K."'
Publikováno v:
In Solid State Electronics January 2015 103:184-189
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Introduction: Lenalidomide plus dexamethasone is effective and well tolerated in relapsed/refractory multiple myeloma (RRMM). In this observational, noninterventional European post-authorization safety study, the safety profile of lenalidomide plus d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c0386c395852d66857b25f34b69f414b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078767
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078767
Publikováno v:
In Cytotherapy 2007 9(6):548-554
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Augustine, B. (Bobins), Remes, K. (Kari), Lorite, G. S. (Gabriela S.), Varghese, J. (Jobin), Fabritius, T. (Tapio)
The predominant expense for the manufacturing cost of new generation photovoltaic devices including perovskite solar cells (PSC) emanate from the use of indium tin oxide (ITO) as transparent electrodes and is due to its limited supply and patterning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::5d68e82094aaefe913fc06075f5e6707
http://urn.fi/urn:nbn:fi-fe2019051615696
http://urn.fi/urn:nbn:fi-fe2019051615696
Publikováno v:
British Journal of Cancer. 2/1/2000, Vol. 82 Issue 3, p601. 7p.
Autor:
Liwing, J., Heeg, B.M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., Anttila, P., Remes, K., Abildgaard, N., Waage, A., Nahi, H.
Publikováno v:
Haematologica, 100:E1277, 512-513. FERRATA STORTI FOUNDATION
Background: Large randomized clinical trials (RCT) are the foundation of the registration of newly developed drugs. A potential problem with RCTs is that the inclusion/exclusion criteria will make the population different from the actual population t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::fe73e54236addb2c447bbb4e38472a61
https://research.rug.nl/en/publications/d2e9cec8-3668-4b2d-8bb1-ceded28bb8ca
https://research.rug.nl/en/publications/d2e9cec8-3668-4b2d-8bb1-ceded28bb8ca
Autor:
Liwing, Johan, Heeg, Bart, Karstorp, Sigrid, Postma, M., Silvennoinen, Raija, Putkonen, M., Anttila , Pekka, Remes, K., Abildgaard , Niels, Waage, Anders, Nahi, Hareth
Publikováno v:
Liwing, J, Heeg, B, Karstorp, S, Postma, M, Silvennoinen, R, Putkonen, M, Anttila, P, Remes, K, Abildgaard, N, Waage, A & Nahi, H 2015, ' Trial efficacy vs real world evidence effectiveness in first line treatment of multiple myeloma ', Haematologica, vol. 100, no. S1, E1277, pp. 512 . < http://www.haematologica.org/content/100/supplement_1/1.full-text.pdf+html >
Liwing, J, Heeg, B, Karstorp, S, Postma, M, Silvennoinen, R, Putkonen, M, Anttila, P, Remes, K, Abildgaard, N, Waage, A & Nahi, H 2015, ' Trial efficacy vs real world evidence effectiveness in first line treatment of multiple myeloma ', 20th Congress of European Hematology Association (EHA), Vienna, Austria, 11/06/2015-14/06/2015 . < http://www.haematologica.org/content/100/supplement_1/1.full-text.pdf+html >
Liwing, J, Heeg, B, Karstorp, S, Postma, M, Silvennoinen, R, Putkonen, M, Anttila, P, Remes, K, Abildgaard, N, Waage, A & Nahi, H 2015, ' Trial efficacy vs real world evidence effectiveness in first line treatment of multiple myeloma ', 20th Congress of European Hematology Association (EHA), Vienna, Austria, 11/06/2015-14/06/2015 . < http://www.haematologica.org/content/100/supplement_1/1.full-text.pdf+html >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::69f56efefb6c6be0f9af490ed1e2fe3d
https://portal.findresearcher.sdu.dk/da/publications/2d34a5a2-2fb3-484a-af0b-94336a5f294f
https://portal.findresearcher.sdu.dk/da/publications/2d34a5a2-2fb3-484a-af0b-94336a5f294f
Autor:
Liwing, J., Heeg, B.M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., Anttila, P., Remes, K., Abildgaard, N., Waage, A., Nahi, H.
Publikováno v:
Liwing, J, Heeg, B, Karstorp, S, Postma, M, Silvennoinen, R, Putkonen, M, Anttila, P, Remes, K, Abildgaard, N, Waage, A & Nahi, H 2015, ' Is a deep response the key to successful treatment of multiple myeloma? ', Haematologica, vol. 100, no. S1, P291, pp. 92 .
Haematologica, 100. FERRATA STORTI FOUNDATION
Haematologica, 100. FERRATA STORTI FOUNDATION
Background: Several authors have highlighted the importance of a deep response to chemotherapy in multiple myeloma (MM), especially in first line. Aims: The objective was to assess which patient/treatment/disease characteristics are prognostic for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7248b6346abdba039e0dc12de426e47e
https://portal.findresearcher.sdu.dk/da/publications/2ce532be-30e7-486c-ad3d-6a18ea12d021
https://portal.findresearcher.sdu.dk/da/publications/2ce532be-30e7-486c-ad3d-6a18ea12d021